PMID- 24416388 OWN - NLM STAT- MEDLINE DCOM- 20140902 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 9 IP - 1 DP - 2014 TI - Inflammatory conditions induce IRES-dependent translation of cyp24a1. PG - e85314 LID - 10.1371/journal.pone.0085314 [doi] LID - e85314 AB - Rapid alterations in protein expression are commonly regulated by adjusting translation. In addition to cap-dependent translation, which is e.g. induced by pro-proliferative signaling via the mammalian target of rapamycin (mTOR)-kinase, alternative modes of translation, such as internal ribosome entry site (IRES)-dependent translation, are often enhanced under stress conditions, even if cap-dependent translation is attenuated. Common stress stimuli comprise nutrient deprivation, hypoxia, but also inflammatory signals supplied by infiltrating immune cells. Yet, the impact of inflammatory microenvironments on translation in tumor cells still remains largely elusive. In the present study, we aimed at identifying translationally deregulated targets in tumor cells under inflammatory conditions. Using polysome profiling and microarray analysis, we identified cyp24a1 (1,25-dihydroxyvitamin D3 24-hydroxylase) to be translationally upregulated in breast tumor cells co-cultured with conditioned medium of activated monocyte-derived macrophages (CM). Using bicistronic reporter assays, we identified and validated an IRES within the 5' untranslated region (5'UTR) of cyp24a1, which enhances translation of cyp24a1 upon CM treatment. Furthermore, IRES-dependent translation of cyp24a1 by CM was sensitive to phosphatidyl-inositol-3-kinase (PI3K) inhibition, while constitutive activation of Akt sufficed to induce its IRES activity. Our data provide evidence that cyp24a1 expression is translationally regulated via an IRES element, which is responsive to an inflammatory environment. Considering the negative feedback impact of cyp24a1 on the vitamin D responses, the identification of a novel, translational mechanism of cyp24a1 regulation might open new possibilities to overcome the current limitations of vitamin D as tumor therapeutic option. FAU - Rubsamen, Daniela AU - Rubsamen D AD - Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany. FAU - Kunze, Michael M AU - Kunze MM AD - Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany. FAU - Buderus, Victoria AU - Buderus V AD - Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany. FAU - Brauss, Thilo F AU - Brauss TF AD - Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany. FAU - Bajer, Magdalena M AU - Bajer MM AD - Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany. FAU - Brune, Bernhard AU - Brune B AD - Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany. FAU - Schmid, Tobias AU - Schmid T AD - Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140108 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (5' Untranslated Regions) RN - 0 (Culture Media, Conditioned) RN - 0 (Phosphoinositide-3 Kinase Inhibitors) RN - 0 (Protein Kinase Inhibitors) RN - EC 1.14.- (Steroid Hydroxylases) RN - EC 1.14.15.16 (CYP24A1 protein, human) RN - EC 1.14.15.16 (Vitamin D3 24-Hydroxylase) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) SB - IM MH - 5' Untranslated Regions MH - Base Sequence MH - Cell Line, Tumor MH - Culture Media, Conditioned/chemistry/*pharmacology MH - Female MH - Gene Expression Profiling MH - *Gene Expression Regulation, Neoplastic MH - Genes, Reporter MH - Humans MH - Inflammation/genetics/metabolism/pathology MH - Macrophages/cytology/metabolism MH - Molecular Sequence Data MH - Oligonucleotide Array Sequence Analysis MH - Phosphatidylinositol 3-Kinases/genetics/metabolism MH - Phosphoinositide-3 Kinase Inhibitors MH - Protein Biosynthesis/*drug effects MH - Protein Kinase Inhibitors/pharmacology MH - Proto-Oncogene Proteins c-akt/genetics/metabolism MH - Ribosomes/*drug effects MH - Signal Transduction MH - Steroid Hydroxylases/*genetics/metabolism MH - Vitamin D3 24-Hydroxylase PMC - PMC3885688 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2014/01/15 06:00 MHDA- 2014/09/03 06:00 PMCR- 2014/01/08 CRDT- 2014/01/14 06:00 PHST- 2013/07/01 00:00 [received] PHST- 2013/12/04 00:00 [accepted] PHST- 2014/01/14 06:00 [entrez] PHST- 2014/01/15 06:00 [pubmed] PHST- 2014/09/03 06:00 [medline] PHST- 2014/01/08 00:00 [pmc-release] AID - PONE-D-13-27103 [pii] AID - 10.1371/journal.pone.0085314 [doi] PST - epublish SO - PLoS One. 2014 Jan 8;9(1):e85314. doi: 10.1371/journal.pone.0085314. eCollection 2014.